We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Get help to classify herbal medicines, vitamins, food preparations, supplements and tonics for import and export.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Check if your import, export or re-export needs a permit or certificate under the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES).
Check the tariff classification for agarose beads chemically modified with 10% by weight of protein A.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
How to use a combination of quantitative and qualitative data to evaluate your digital health product.
Guidance for manufacturers, importers and distributors.
Volume 32 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
The MHRA will introduce a patient alert card to increase awareness among men taking finasteride about potential psychiatric and sexual side effects
Using an ecological momentary assessment to evaluate your digital health product.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
How to apply for marketing authorisation via this new procedure.
Find out how to import timber and wood material, including the documents, identity checks and plant health inspections required.
Check the tariff classification for peptide nisin standardised with sodium chloride
Further measures to be introduced to ensure patients who are prescribed montelukast for the treatment of asthma are informed of the risk of neuropsychiatric reactions
Find out about coronavirus (COVID-19) treatments available outside of hospital, including information on free prescriptions and lateral flow tests.
How to use a patient-reported outcomes and experiences study to evaluate your digital health product.
The review of the safety of isotretinoin has concluded.
Certificates you can use when zero rating goods or services under the VAT Act 1994, Schedule 8, Group 15, items 4 to 6.
Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.